Search

Human Milk Oligosaccharides (HMO) Market

Human Milk Oligosaccharides (HMO) Market Size by Application (Food Supplement, Infant Formula, Dietary Supplements, Functional Food and Beverage), Type (2’FL, 3’FL, 3’SL, and 6’SL), Concentration (Neutral, and Acidic), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-12904
  • Published Date: Sep, 2022
  • Pages: 238
  • Category: Food & Beverages
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The Global Human Milk Oligosaccharides (HMO) market is expected to reach USD 1009.3 million by 2030, at a CAGR of 22.80% from 2022 to 2030. Human Milk Oligosaccharides (HMO) market growth would be driven by the rising customer problems about gut health and the increasing consumption of nutritional supplements, which are anticipated to propel the development of the market. Human Milk Oligosaccharides (HMO) function as prebiotics in the human body and support and strengthen stomach health.

Market Overview:

The essential element affecting the market growth is customers' growing understanding of the demand to strengthen gut microbiota in newborns for their health and development, including expensive techniques resulting in the increased price of Human Milk Oligosaccharides, which negatively affects the market's growth. Further, the restricting factor is the replacement of HMOs with the same functional benefits. As consumers become more health concerned, Human Milk Oligosaccharides are now used as a healthy ingredient in various usable foods and drinks. The availability of the latest technologies, like the enzymatic trans glycosylation technique to form Human Milk Oligosaccharides artificially, has also contributed to the market's growth. Additionally, the use of different health products, such as food or dietary supplements, has developed due to the demand for Human Milk Oligosaccharides. The accessibility of the latest technologies, like enzymatic trans-glycosylation, which is used to mix the Human Milk Oligosaccharides artificially, is one of the critical causes and market trends that push the development of the Human Milk Oligosaccharides (HMO) Market. However, customers are aware of the expensive food products' health benefits, and their increased prices stop them from buying. The features affect developing countries with price-sensitive clients, especially in Asian and African countries.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:
  • Increasing need for Human Milk Oligosaccharides in the newborn formula

The increasing need for Human Milk Oligosaccharides in the newborn formula is anticipated to propel market growth. It is due to different advantages of Human Milk Oligosaccharides associated with newborn health. Human Milk Oligosaccharides help Bifidobacterium genus in individuals and are essential bioactive ingredients in mother's milk that help newborn health by stimulating stomach microbial colonization and expansion. The large quantity of Human Milk Oligosaccharides can be manufactured in adequate amounts to be utilized in infant formula, even though over 195 different Human Milk Oligosaccharides have been discovered and ranked. Human Milk Oligosaccharides are also helpful to immunological and digestive systems.

Restraints:
  • The increased price of production linked with HMO

Human Milk Oligosaccharides products' expansion and commercial factors are complicated, costly, and doubtful. Technological requirements, customer needs, and regulatory & legislative background are behind product expansion success. Significant investment is needed for the research & development of a specific type of Human Milk Oligosaccharides to make dietary supplements or different operating food like prebiotics. These items are produced and created by international food regulations.

Opportunities:
  • The exposure to substitutional animal milk oligosaccharides

Bovine milk oligosaccharides are anticipated to recreate a critical role in newborn nourishment. The goat milk newborn formula has comparable prebiotic properties to breast milk and is predicted to play an essential role in the gut health of newborns. Ausnutria Nutrition BV (Netherlands) presents goat milk-based newborn formulas under the Kabrita brand.

Segmentation Analysis:

The global Human Milk Oligosaccharides (HMO) market has been segmented based on application, type, concentration, and region.

  • The application segment is divided into food supplement, infant formula, dietary supplements, functional food, and beverage. The infant formula segment dominated the market, with a market share of around 27% in 2021. The need for Human Milk Oligosaccharides in preparing infant formulas is growing due to the valuable properties of Human Milk Oligosaccharides, like preventing illness, prebiotic outcomes, memory enhancement, brain evolution, and gut health care.
  • The type segment is divided into 2’FL, 3’FL, 3’SL, and 6’SL. The 2’FL segment dominated the market, with a market share of around 26% in 2021. Owing to three different bifidobacterial species, including B. dentium, B. bifidum, and B. infantis, 2’FL only increases in the intestine Bifidobacterium.
  • The concentration segment is divided into neutral, and acidic. The neutral segment dominated the market, with a market share of around 54% in 2021. Neutral Human Milk Oligosaccharides account for more than 76% of the total HMOs in human breast milk.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East and Africa. North America region emerged as the largest market for the global Human Milk Oligosaccharides (HMO) market with a 34.5% share of the market revenue in 2021.

  • North America currently dominates the Human Milk Oligosaccharides (HMO) market due to the multiple primary infant formula and newborn food manufacturers and technological advances are anticipated to grow in the regional market during the projection period. The Asia Pacific Human Milk Oligosaccharides market is predicted to be made owing to the rising people, death rate, disposable earnings, and customer understanding of hygiene and health. Increasing concerns regarding gut disorders, diabetes, increased blood pressure, rickets, and other severe diseases, have resulted in the increased need for functioning food and beverages, which is anticipated to drive the regional market for human milk oligosaccharides.

North America Region Human Milk Oligosaccharides (HMO) Market Share in 2021 - 34.5%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global human milk oligosaccharides (HMO) industry.

In March 2022, (HH Group) Health & Happiness, which is a significant nutrition firm, declared that it is pioneering research on how the proper pairings of Human Milk Oligosaccharides and prebiotics, which is an unknown type known as HMObiotics, could get about health advantages for customers across various age groups.

List of Key Market Players:

  • Royal Friesland Campina N.V
  • Nestle
  • Inbiose N.V
  • Gnubiotics Sciences S.A
  • Elicityl S.A
  • DUPONT
  • DSM
  • Dextra Laboratories
  • CHR Hansen Holding A/S
  • Biosynth Carbosynth
  • BASF SE
  • Abbott Laboratories

Key Target Audience

  • Hospitals
  • Food and Beverage
  • Bakery
  • Dairy
  • Market Players
  • Investors
  • End-users
  • Government Authorities
  • Consulting And Research Firm
  • Venture capitalists
  • Third-party knowledge providers

Report Description:

  • Global Human Milk Oligosaccharides (HMO) Market, Industry Analysis, Trends, Analysis and Forecast, 2022 to 2030 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2021 is considered as the base year of the report. 2019 and 2020 are considered as the historic years and 2022 to 2030 are the forecast years. The global Human Milk Oligosaccharides (HMO) market is based on revenue (USD Million). The report incorporates the market study based on revenue. The study covers the market share revenue/market share/volume for each of the segments, regions and countries catering to global Human Milk Oligosaccharides (HMO) market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts across the globe. The research report also delivers an outline of the attractiveness of Human Milk Oligosaccharides (HMO) based on application, type, concentration, and regions which are deduced and formulated based on their growth rate (CAGR), market size, and attractiveness by analyzing the present and prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global Human Milk Oligosaccharides (HMO) market. This offers vital and in-depth insights to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global Human Milk Oligosaccharides (HMO) market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario.
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors.
  • Potential growth prospects along with the penetration rate analysis of the product (market related i.e., global Human Milk Oligosaccharides (HMO) market) is covered to comprehend the adoption rate and evaluate the market size. 

Frequesntly Asked Questions

As per The Brainy Insights, the size of the Human Milk Oligosaccharides (HMO) market was valued at USD 158.95 million in 2021 to USD 1009.3 million by 2030.

Global Human Milk Oligosaccharides (HMO) market is growing at a CAGR of 22.80% during the forecast period 2022-2030.

North America region emerged as the largest market for the Human Milk Oligosaccharides (HMO) market.

Increasing need for Human Milk Oligosaccharides in the new-born formula to propel market growth.

The increased price of production linked with HMO to hinder market growth.

The exposure to substitutional animal milk oligosaccharides will provide huge opportunities to the market.

Key players are Royal Friesland Campina N.V, Nestle, Inbiose N.V , Gnubiotics Sciences S.A, Elicityl S.A, DUPONT, DSM, Dextra Laboratories, CHR Hansen Holding A/S, Biosynth Carbosynth, BASF SE, and Abbott Laboratories.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Application
          4.3.2. Market Attractiveness Analysis by Type
          4.3.3. Market Attractiveness Analysis by Concentration
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing need for Human Milk Oligosaccharides in the new-born formula to propel market growth
    5.3. Restraints
          5.3.1. The increased price of production linked with HMO to Hinder Market Growth
    5.4. Opportunities
          5.4.1. The exposure to substitutional animal milk oligosaccharides

6. Global Human Milk Oligosaccharides (HMO) Market Analysis and Forecast, By Application:
    6.1. Segment Overview
    6.2. Food Supplement
    6.3. Infant Formula
    6.4. Dietary Supplements
    6.5. Functional Food and Beverage

7. Global Human Milk Oligosaccharides (HMO) Market Analysis and Forecast, By Type
    7.1. Segment Overview
    7.2. 2’FL
    7.3. 3’FL
    7.4. 3’SL
    7.5. 6’SL

8. Global Human Milk Oligosaccharides (HMO) Market Analysis and Forecast, By Concentration
    8.1. Segment Overview
    8.2. Neutral
    8.3. Acidic

9. Global Human Milk Oligosaccharides (HMO) Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Human Milk Oligosaccharides (HMO) Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Human Milk Oligosaccharides (HMO) Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Royal Friesland Campina N.V
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Nestle
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Inbiose N.V
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Gnubiotics Sciences S.A
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Elicityl S.A
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. DUPONT
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. DSM
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Dextra Laboratories.
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. CHR Hansen Holding A/S
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Biosynth Carbosynth
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. BASF SE
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Abbott Laboratories
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
 

List of Table

1. Global Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

2. Global Food Supplement Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion) 

3. Global Infant Formula Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion) 

4. Global Dietary Supplements Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion) 

5. Global Functional Food and Beverage Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion) 

6. Global Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

7. Global 2’FL Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion) 

8. Global 3’FL Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion)

9. Global 3’SL Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion)

10. Global 6’SL Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion)

11. Global Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

12. Global Neutral Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion) 

13. Global Acidic Human Milk Oligosaccharides (HMO) Market, By Region, 2019-2030 (USD Billion)

14. North America Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

15. North America Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

16. North America Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

17. U.S. Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

18. U.S. Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

19. U.S. Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

20. Canada Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

21. Canada Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

22. Canada Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

23. Mexico Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

24. Mexico Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

25. Mexico Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

26. Europe Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

27. Europe Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

28. Europe Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

29. Germany Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

30. Germany Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

31. Germany Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

32. France Human Milk Oligosaccharides (HMO) Market, By Application 2019-2030 (USD Billion) 

33. France Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

34. France Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

35. U.K. Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

36. U.K. Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

37. U.K. Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

38. Italy Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

39. Italy Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

40. Italy Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

41. Spain Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

42. Spain Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

43. Spain Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

44. Asia Pacific Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

45. Asia Pacific Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

46. Asia Pacific Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

47. Japan Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

48. Japan Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

49. Japan Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

50. China Human Milk Oligosaccharides (HMO) Market, By Application 2019-2030 (USD Billion) 

51. China Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

52. China Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

53. India Human Milk Oligosaccharides (HMO) Market, By Application 2019-2030 (USD Billion) 

54. India Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

55. India Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

56. South America Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

57. South America Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

58. South America Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion)

59. Brazil Human Milk Oligosaccharides (HMO) Market, By Application 2019-2030 (USD Billion) 

60. Brazil Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

61. Brazil Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

62. Middle East and Africa Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

63. Middle East and Africa Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

64. Middle East and Africa Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

65. UAE Human Milk Oligosaccharides (HMO) Market, By Application, 2019-2030 (USD Billion) 

66. UAE Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

67. UAE Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion) 

68. South Africa Human Milk Oligosaccharides (HMO) Market, By Application 2019-2030 (USD Billion) 

69. South Africa Human Milk Oligosaccharides (HMO) Market, By Type, 2019-2030 (USD Billion) 

70. South Africa Human Milk Oligosaccharides (HMO) Market, By Concentration, 2019-2030 (USD Billion)  

List of Figures 

1. Global Human Milk Oligosaccharides (HMO) Market Segmentation

2. Human Milk Oligosaccharides (HMO) Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Human Milk Oligosaccharides (HMO) Market Attractiveness Analysis by Application

9. Global Human Milk Oligosaccharides (HMO) Market Attractiveness Analysis by Type

10. Global Human Milk Oligosaccharides (HMO) Market Attractiveness Analysis by Concentration

11. Global Human Milk Oligosaccharides (HMO) Market Attractiveness Analysis by Region

12. Global Human Milk Oligosaccharides (HMO) Market: Dynamics

13. Global Human Milk Oligosaccharides (HMO) Market Share by Application (2022 & 2030)

14. Global Human Milk Oligosaccharides (HMO) Market Share by Type (2022 & 2030)

15. Global Human Milk Oligosaccharides (HMO) Market Share by Concentration (2022 & 2030)

16. Global Human Milk Oligosaccharides (HMO) Market Share by Regions (2022 & 2030)

17. Global Human Milk Oligosaccharides (HMO) Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global Human Milk Oligosaccharides (HMO) Market based on below mentioned segments:

Global Human Milk Oligosaccharides (HMO) Market by Application:

  • Food Supplement
  • Infant Formula
  • Dietary Supplements
  • Functional Food and Beverage

Global Human Milk Oligosaccharides (HMO) Market by Type:

  • 2’FL
  • 3’FL
  • 3’SL
  • 6’SL

Global Human Milk Oligosaccharides (HMO) Market by Concentration:

  • Neutral
  • Acidic

Global Human Milk Oligosaccharides (HMO) Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date